Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simultaneous Administration of Norepinephrine, Angiotensin II, and Vasopressin in Septic Shock Patients

NCT06155812 is registered in ClinicalTrials.gov with University Medical Centre Maribor as lead sponsor.

NCT NCT06155812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06155812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Simultaneous Administration of Norepinephrine, Angiotensin II, and Vasopressin in Septic Shock Patients
Lead sponsor
University Medical Centre Maribor
Phase
Phase 2/3
Overall status
Completed
Start date
December 23, 2023
Completion date
February 1, 2026
Enrollment
79 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

shock, septic